文献速递淋巴瘤浆细胞疾病白血病

美国老年血液肿瘤患者癌前及癌相关抑郁与焦虑的流行病学研究

Precancer and cancer-associated depression and anxiety among older adults with blood cancers in the United States.
PubMed 文献 · Blood Adv · 2022-01-01

该研究利用监测、流行病学和最终结果(SEER)-医疗保险数据库,纳入2000至2015年确诊的75 691例≥67岁淋巴瘤、骨髓瘤、白血病或骨髓增生异常综合征患者,18.6%至少有一次抑郁或焦虑诊断,13.7%有癌前抑郁和/或焦虑,4.9%有癌相关抑郁或焦虑。癌前焦虑者后续癌相关抑郁风险升高(OR 2.98;95% CI 2.61-3.41),癌前抑郁者后续癌相关焦虑风险升高(OR 3.01;95% CI 2.63-3.44)。

要点

  • 75 691例老年血液肿瘤患者中18.6%至少有一次抑郁或焦虑诊断。
  • 癌前焦虑者后续癌相关抑郁风险升高(OR 2.98;95% CI 2.61-3.41)。
  • 癌前抑郁者后续癌相关焦虑风险升高(OR 3.01;95% CI 2.63-3.44)。

核心结论

  • 在该大型老年新诊断血液肿瘤队列中,近五分之一患者存在抑郁或焦虑,作者认为凸显了该人群系统心理健康筛查和管理的迫切需求。

研究设计与样本

  • 利用监测、流行病学和最终结果(SEER)-医疗保险数据库,识别2000至2015年确诊的≥67岁淋巴瘤、骨髓瘤、白血病或骨髓增生异常综合征患者,共75 691例,基于索赔数据判定癌前及癌相关抑郁和焦虑,并用多因素分析寻找相关因素。

主要发现

  • 75 691例患者中18.6%至少有一次抑郁或焦虑诊断。
  • 全队列中13.7%有癌前抑郁和/或癌前焦虑,4.9%有癌相关抑郁或癌相关焦虑。
  • 与无癌前焦虑者相比,癌前焦虑者后续癌相关抑郁索赔更常见(OR 2.98;95% CI 2.61-3.41)。
  • 与无癌前抑郁者相比,癌前抑郁者后续癌相关焦虑索赔更常见(OR 3.01;95% CI 2.63-3.44)。
  • 癌相关抑郁风险较高的其他因素包括女性、非已婚状态、更高合并症负担和骨髓瘤诊断;女性及骨髓瘤诊断也与癌相关焦虑相关。

关键数值与推荐

  • 癌前焦虑与后续癌相关抑郁的关联:OR 2.98;95% CI 2.61-3.41。
  • 癌前抑郁与后续癌相关焦虑的关联:OR 3.01;95% CI 2.63-3.44。
  • 全队列至少一次抑郁或焦虑诊断的患病率为18.6%。
  • 癌前抑郁和/或癌前焦虑的患病率为13.7%。
  • 癌相关抑郁或癌相关焦虑的患病率为4.9%。

临床怎么用

  • 作者认为该人群需要系统心理健康筛查和管理,原文未给出具体筛查工具或干预方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

For patients with blood cancers, comorbid mental health disorders at diagnosis likely affect the entire disease trajectory, as they can interfere with disease information processing, lead to poor coping, and even cause delays in care. We aimed to characterize the prevalence of depression and anxiety in patients with blood cancers. Using the Surveillance, Epidemiology, and End Results-Medicare database, we identified patients ≥67 years old diagnosed with lymphoma, myeloma, leukemia, or myelodysplastic syndromes between 2000 and 2015. We determined the prevalence of precancer depression and anxiety and cancer-associated (CA) depression and anxiety using claims data. We identified factors associated with CA-depression and CA-anxiety in multivariate analyses. Among 75 691 patients, 18.6% had at least 1 diagnosis of depression or anxiety. Of the total cohort, 13.7% had precancer depression and/or precancer anxiety, while 4.9% had CA-depression or CA-anxiety. Compared with patients without precancer anxiety, those with precancer anxiety were more likely to have subsequent claims for CA-depression (odds ratio [OR] 2.98; 95% CI 2.61-3.41). Other factors associated with a higher risk of CA- depression included female sex, nonmarried status, higher comorbidity, and myeloma diagnosis. Patients with precancer depression were significantly more likely to have subsequent claims for CA-anxiety compared with patients without precancer depression (OR 3.01; 95% CI 2.63-3.44). Female sex and myeloma diagnosis were also associated with CA-anxiety. In this large cohort of older patients with newly diagnosed blood cancers, almost 1 in 5 suffered from depression or anxiety, highlighting a critical need for systematic mental health screening and management for this population.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Kuczmarski TM, Jaung T, Mancuso CE, et al. Precancer and cancer-associated depression and anxiety among older adults with blood cancers in the United States. Blood Adv. 2022. PMID: 34872105. doi:10.1182/bloodadvances.2021005862

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。